GENE TARGETING IN MOUSE EMBRYONIC STEM-CELLS WITH AN ADENOVIRAL VECTOR

被引:23
作者
MITANI, K
WAKAMIYA, M
HASTY, P
GRAHAM, FL
BRADLEY, A
CASKEY, CT
机构
[1] BAYLOR COLL MED, DEPT MOLEC & HUMAN GENET, HOUSTON, TX 77030 USA
[2] BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA
[3] UNIV TEXAS, MD ANDERSON CANC CTR, DEPT BIOCHEM & MOLEC BIOL, HOUSTON, TX 77030 USA
[4] MCMASTER UNIV, DEPT BIOL, TORONTO, ON L8S 4K1, CANADA
关键词
D O I
10.1007/BF02255777
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the ability of an EI, E3-defective adenoviral vector to act as a substrate for homologous recombination with chromosomal DNA by including host chromosomal sequence from the mouse Fgr locus that also contained a selectable marker. After infection of mouse embryonic stem cells, stable integration was selected for neomycin resistance and the efficiency of homologous recombination was evaluated. The adenoviral vector was capable of infecting mouse embryonic stem cells efficiently. Between 30-50% of the input virus reached the nuclei after 24 hours of infection. Surprisingly, even without negative selection, 25-40% of the integration resulted from homologous recombination at m.o.i 10 and 100, although the absolute efficiency of integration was low. Our results suggest that it is possible to modify the structure of an adenoviral vector to achieve a high gene targeting efficiency, resulting in regulated and long-term expression of an introduced gene.
引用
收藏
页码:221 / 231
页数:11
相关论文
共 28 条
[1]   PACKAGING CAPACITY AND STABILITY OF HUMAN ADENOVIRUS TYPE-5 VECTORS [J].
BETT, AJ ;
PREVEC, L ;
GRAHAM, FL .
JOURNAL OF VIROLOGY, 1993, 67 (10) :5911-5921
[2]   AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[3]   MODIFYING THE MOUSE - DESIGN AND DESIRE [J].
BRADLEY, A ;
HASTY, P ;
DAVIS, A ;
RAMIREZSOLIS, R .
BIO-TECHNOLOGY, 1992, 10 (05) :534-539
[4]  
Brickell Paul M., 1992, Critical Reviews in Oncogenesis, V3, P401
[5]   ADENOVIRUS-MEDIATED IN-VIVO GENE-TRANSFER [J].
BRODY, SL ;
CRYSTAL, RG .
GENE THERAPY FOR NEOPLASTIC DISEASES, 1994, 716 :90-103
[6]   CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS [J].
COLLINS, FS .
SCIENCE, 1992, 256 (5058) :774-779
[7]  
Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109
[8]   CHARACTERISTICS OF A HUMAN CELL LINE TRANSFORMED BY DNA FROM HUMAN ADENOVIRUS TYPE-5 [J].
GRAHAM, FL ;
SMILEY, J ;
RUSSELL, WC ;
NAIRN, R .
JOURNAL OF GENERAL VIROLOGY, 1977, 36 (JUL) :59-72
[9]   THE ROLE AND FATE OF DNA ENDS FOR HOMOLOGOUS RECOMBINATION IN EMBRYONIC STEM-CELLS [J].
HASTY, P ;
RIVERAPEREZ, J ;
BRADLEY, A .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2464-2474
[10]   EFFICIENCY OF INSERTION VERSUS REPLACEMENT VECTOR TARGETING VARIES AT DIFFERENT CHROMOSOMAL LOCI [J].
HASTY, P ;
CRIST, M ;
GROMPE, M ;
BRADLEY, A .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (12) :8385-8390